CBP and p300: Versatile coregulators with important roles in hematopoietic gene expression

Journal of Leukocyte Biology

Volumn 71, Issue 4, 2002, Pages 545-556

  Blobel, Gerd A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

CBP p300; Chromatin; Coactivators; Hematopoiesis; Transcription

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; ERYTHROID KRUPPEL LIKE FACTOR; HELIX LOOP HELIX PROTEIN; HISTONE; PROTEIN P300; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2;

ACETYLATION; ANIMAL CELL; CELL CYCLE; CELL TYPE; CHROMATIN; DNA BINDING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY;

ACETYLATION; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CREB-BINDING PROTEIN; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0036553915     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (152)

1. McManus, K. J., Hendzel, M. J. (2001) CBP, a transcriptional coactivator and acetyltransferase. Biochem. Cell Biol. 79, 253-266.
2. Vo, N., Goodman, R. H. (2001) CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276, 13505-13508.
3. Goodman, R. H., Smolik, S. (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577.
4. Shikama, N., Lyon, J., LaThangue, N. B. (1997) The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7, 230-236.
5. Giles, R. H., Peters, D. J. M., Breuning, M. H. (1998) Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14, 178-183.
6. Eckner, R. (1996) p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377, 685-688.
7. Blobel, G. A. (2000) CBP/p300: molecular integrators of hematopoietic transcription. Blood 95, 745-755.
8. Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., Goodman, R. G. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (London) 365, 855-859.
9. Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., Livingston, D. M. (1994) Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kd protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884.
10. Moran, E. (1993) DNA tumor transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70.
11. Zanger, K., Radovick, S., Wondisford, F. E. (2001) CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol. Cell 7, 551-558.
12. Soutoglou, E., Katrakili, N., Talianidis, I. (2000) Acetylation regulates transcription factor activity at multiple levels. Mol. Cell 5, 745-751.
13. Polesskaya, A., Naguibneva, I., Duquet, A., Bengal, E., Robin, P., Harel-Bellan, A. (2001) Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. Mol. Cell. Biol. 21, 5312-5320.
14. Bannister, A. J., Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature (London) 384, 641-643.
15. Ogryzko, V. V., Schiltz, L. R., Russanova, V., Howard, B. H., Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
16. Yang, X-J., Ogrysko, V. V., Nishikawa, J., Howard, B. H., Nakatani, Y. (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (London) 382, 319-324.
17. Xu, W., Edmondson, D. G., Roth, S. Y. (1998) Mammalian GCN5 and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates. Mol. Cell. Biol. 18, 5659-5669.
18. Torchia, J., Glass, C., Rosenfeld, M. G. (1998) Co-activators and corepressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10, 373-383.
19. Kuo, M. H., Allis, C. D. (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20, 615-626.
20. Lundblad, J. R., Kwok, R. P., Laurance, M. E., Harter, M. L., Goodman, R. H. (1995) Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88.
21. Arany, Z., Newsome, D., Oldread, E., Livingston, D. M., Eckner, R. (1995) A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374, 81-84.
22. Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H. Y., Wang, J. Y., Nakatani, Y., Kedes, L. (1999) Regulation of histone acetyltrans-ferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96, 405-413.
23. Chakravarti, D., Ogryzko, V., Kao, H. Y., Nash, A., Chen, H., Nakatani, Y., Evans, R. M. (1999) A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403.
24. Perissi, V., Dasen, J. S., Kurokawa, R., Wang, Z., Korzus, E., Rose, D. W., Glass, C. K., Rosenfeld, M. G. (1999) Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc. Natl. Acad. Sci. USA 96, 3652-3657.
25. Chen, C. J., Deng, Z., Kim, A. Y., Blobel, G. A., Lieberman, P. M. (2001) Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol. Cell. Biol. 21, 476-487.
26. Zhang, Q., Vo, N., Goodman, R. H. (2000) Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB. Mol. Cell. Biol. 20, 4970-4978.
27. Ait-Si-Ali, S., Ramirez, S., Barre, F. X., Dkhissi, F., Magnaghi-Jaulin, L., Girault, J. A., Robin, P., Knibiehler, M., Pritchard, L. L., Ducommun, B., Trouche, D., Harel-Bellan, A. (1998) Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature (London) 396, 184-186.
28. Ait-Si-Ali, S., Carlisi, D., Ramirez, S., Upegui-Gonzalez, L. C., Duquet, A., Robin, P., Rudkin, B., Harel-Bellan, A., Trouche, D. (1999) Phosphorylation by p44 MAP Kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro. Biochem. Biophys. Res. Commun. 262, 157-162.
29. O'Connor, M. J., Zimmermann, H., Nielsen, S., Bernard, H. U., Kouzarides, T. (1999) Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J. Virol. 73, 3574-3581.
30. Horn, P. J., Peterson, C. L. (2001) The bromodomain: a regulator of ATP-dependent chromatin remodeling? Front Biosci. 6, D1019-D1023.
31. Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M-M. (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature (London) 399, 491-496.
32. Kraus, W. L., Manning, E. T., Kadonaga, J. T. (1999) Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol. Cell. Biol. 19, 8123-8135.
33. Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C., Masuno, M., Tommerup, N., van Ommen, G. B., Goodman, R. H., Peters, D. J. M., Breuning, M. H. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (London) 376, 348-351.
34. Rubinstein, J. H., Taybi, H. (1963) Broad thumbs and toes and facial abnormalities: a possible mental retardation syndrome. Am. J. Dis. Child. 105, 588-608.
35. Miller, R. W., Rubinstein, J. H. (1995) Tumors in Rubinstein-Taybi syndrome. Am. J. Med. Gen. 56, 112-115.
36. Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L. E., Sieff, C. A., Livingston, D. M., Yao, T. P. (2000) Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14, 272-277.
37. Muraoka, M., Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Shitara, N., Chong, J. M., Iwama, T., Miyaki, M. (1996) p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12, 1565-1569.
38. Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S. F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., Delhanty, J. D., Ponder, B. A., Kouzarides, T., Caldas, C. (2000) Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24, 300-303.
39. Bayley, S. T., Mymryk, J. S. (1994) Adenovirus E1A proteins and transformation. Int. J. Oncol. 5, 425-444.
40. Fuchs, M., Gerber, J., Drapkin, R., Sif, S., Ikura, T., Ogryzko, V., Lane, W. S., Nakatani, Y., Livingston, D. M. (2001) The p400 complex is an essential E1A transformation target. Cell 106, 297-307.
41. Borrow, J., Stanton, V. P. J., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dube, I., Frischauf, A. M., Horsman, D., Mitelman, F., Volinia, S., Watmore, A. E., Housman, D. E. (1996) The translocation t(8;16)(p11;13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14, 33-41.
42. Champagne, N., Pelletier, N., Yang, X. J. (2001) The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 20, 404-409.
43. Kitabayashi, I., Aikawa, Y., Yokoyama, A., Hosoda, F., Nagai, M., Kakazu, N., Abe, T., Ohki, M. (2001) Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia 15, 89-94.
44. Chaffanet, M., Gressin, L., Preudhomme, C., Soenen-Cornu, V., Birnbaum, D., Pebusque, M. J. (2000) MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 28, 138-144.
45. Rowley, J. D., Reshmi, S., Sobulo, O., Musvee, T., Anastasi, J., Raimondi, S., Schneider, N. R., Barredo, J. C., Cantu, E. S., Schlegelberger, B., Behm, F., Doggett, N. A., Borrow, J., Zeleznik-Le, N. (1997) All patients with the T(11;16) (q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90, 535-541.
46. Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N. A., Rowley , J. D., Zeleznik-Le, N. J. (1997) MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc. Natl. Acad. Sci. USA 94, 8732-8737.
47. Taki, T., Sako, M., Tsuchida, M., Hayashi, Y. (1997) The t(11; 16)(q2313.3) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89, 3945-3950.
48. Satake, N., Ishida, Y., Otoh, Y., Hinohara, S., Kobayashi, H., Sakashita, A., Maseki, N., Kaneko, Y. (1997) Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation. Genes Chromosomes Cancer 20, 60-63.
49. Ayton, P. M., Cleary, M. L. (2001) MLL in normal and malignant hematopoiesis. In Transcription Factors. Normal and Malignant Development of Blood Cells (K. Ravid, J. Licht, eds.) Wiley-Liss, Inc., N.Y. 447-463.
50. Lavau, C., Du, C., Thirman, M., Zeleznik-Le, N. (2000) Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J. 19, 4655-4664.
51. Ida, K., Kitabayashi, I., Taki, T., Taniwaki, M., Noro, K., Yamamoto, M., Ohki, M., Hayashi, Y. (1997) Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11,22)(q23;q13). Blood 90, 4699-4704.
52. Champagne, N., Bertos, N. R., Pelletier, N., Wang, A. H., Vezmar, M., Yang, Y., Heng, H. H., Yang, X. J. (1999) Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J. Biol. Chem. 274, 28528-28536.
53. Panagopoulos, I., Fioretos, T., Isaksson, M., Samuelsson, U., Billstrom, R., Strombeck, B., Mitelman, F., Johansson, B. (2001) Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22; p13). Hum. Mol. Genet. 10, 395-404.
54. Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T., Ishii, S. (1997) Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi. Proc. Natl. Acad. Sci. USA 94, 10215-10220.
55. Oike, Y., Hata, A., Mamiya, T., Kaname, T., Noda, Y., Suzuki, M., Yasue, H., Nabeshima, T., Araki, K., Yamamura, K. (1999) Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet. 8, 387-396.
56. Yao, T-P., Oh, S. P., Fuchs, M., Zhou, N-D., Ch'ng, L-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., Eckner, R. (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372.
57. Tanaka, Y., Naruse, I., Hongo, T., Xu, M., Nakahata, T., Maekawa, T., Ishii, S. (2000) Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech. Dev. 95, 133-145.
58. Oike, Y., Takakura, N., Hata, A., Kaname, T., Akizuki, M., Yamaguchi, Y., Yasue, H., Araki, K., Yamamura, K. I., Suda, T. (1999) Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93, 2771-2779.
59. Yamamoto, H., Kihara-Negishi, F., Yamada, T., Hashimoto, Y., Oikawa, T. (1999) Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP. Oncogene 18, 1495-1501.
60. Dai, P., Akimaru, H., Tanaka, Y., Hou, D-X., Yasukawa, T., Kanei-Ishii, C., Takahashi, T., Ishii, S. (1995) CBP as a transcriptional coactivator of c-Myb. Genes Dev. 10, 528-540.
61. Oelgeschläger, M., Janknecht, R., Krieg, J., Schreek, S., Lüscher, B. (1996) Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J. 15, 2771-2780.
62. Higgs, D. R. (1998) Do LCRs open chromatin domains? Cell 95, 299-302.
63. Engel, J. D., Tanimoto, K. (2000) Looping, linking, and chromatin activity: new insights into beta-globin locus regulation. Cell 100, 499-502.
64. Epner, E., Reik, A., Cimbora, D., Telling, A., Bender, M. A., Fiering, S., Enver, T., Martin, D. I. K., Kennedy, M., Keller, G., Groudine, M. (1998) The β-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse β-globin locus. Mol. Cell 2, 447-455.
65. Reik, A., Telling, A., Zitnik, G., Cimbora, D., Epner, E., Groudine, M. (1998) The locus control region is necessary for gene expression in the human beta-globin locus but not for the maintenance of an open chromatin structure in erythroid cells. Mol. Cell. Biol. 18, 5992-6000.
66. Hebbes, T. R., Clayton, A. L., Thorne, A. W., Crane-Robinson, C. (1994) Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken β-globin chromosomal domain. EMBO J. 13, 1823-1830.
67. Schübeler, D., Francastel, C., Cimbora, D. M., Reik, A., Martin, D. I., Groudine, M. (2000) Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus. Genes Dev. 14, 940-950.
68. Forsberg, E. C., Downs, K. M., Christensen, H. M., Im, H., Nuzzi, P. A., Bresnick, E. H. (2000) Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc. Natl. Acad. Sci. USA 97, 14494-14499.
69. Litt, M. D., Simpson, M., Recillas-Targa, F., Prioleau, M. N., Felsenfeld, G. (2001) Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J. 20, 2224-2235.
70. Hebbes, T. R., Thorne, A. W., Clayton, A. L., Crane-Robinson, C. (1992) Histone acetylation and globin gene switching. Nucleic Acids Res. 20, 1017-1022.
71. Schabeler, D., Groudine, M., Bender, M. A. (2001) The murine beta-globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc. Natl. Acad. Sci. USA 98, 11432-11437.
72. Blobel, G. A., Nakajima, T., Eckner, R., Montminy, M., Orkin, S. H. (1998) CREB-binding protein (CBP) cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl. Acad. Sci. USA 95, 2061-2066.
73. Boyes, J., Byfield, P., Nakatani, Y., Ogryzko, V. (1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396, 594-598.
74. Hung, H-L., Lau, J., Weiss, M. J., Blobel, G. A. (1999) CREB-binding protein (CBP) acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol. Cell. Biol. 19, 3496-3505.
75. Hung, H. L., Kim, A. Y., Hong, W., Rakowski, C., Blobel, G. A. (2001.) Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation. J. Biol. Chem. 276, 10715-10721.
76. Cheng, X., Reginato, M. J., Andrews, N. C., Lazar, M. A. (1997) The Transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2. Mol. Cell. Biol. 1, 1407-1416.
77. Forsberg, E. C., Johnson, K., Zaboikina, T. N., Mosser, E. A., Bresnick, E. H. (1999) Requirement of an E1A-sensitive coactivator for long-range transactivation by the β-globin locus control region. J. Biol. Chem. 274, 26850-26859.
78. Zhang, W., Bieker, J. J. (1998) Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyl-transferases. Proc. Natl. Acad. Sci. USA 95, 9855-9860.
79. Zhang, W., Kadam, S., Emerson, B. M., Bieker, J. J. (2001.) Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol. Cell. Biol. 21, 2413-2422.
80. Huang, S., Qiu, Y., Stein, R. W., Brandt, S. J. (1999) p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene 18, 4958-4967.
81. Huang, S., Qiu, Y., Shi, Y., Xu, Z., Brandt, S. J. (2000) P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J. 19, 6792-6803.
82. Weiss, M. J., Orkin, S. H. (1995) GATA transcription factors: key regulators of hematopoiesis. Exp. Hemtol. 23, 99-107.
83. Fujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C., Orkin, S. H. (1996) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 93, 12355-12358.
84. Weiss, M. J., Keller, G., Orkin, S. H. (1994) Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells. Genes Dev. 8, 1184-1197.
85. Weiss, M. J., Orkin, S. H. (1995) Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. USA 92, 9623-9627.
86. Yamagata, T., Mitani, K., Oda, H., Suzuki, T., Honda, H., Asai, T., Maki, K., Nakamoto, T., Hirai, H. (2000) Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs. EMBO J. 19, 4676-4687.
87. Blank, V., Andrews, N. C. (1997) The maf transcription factors: regulators of differentiation. Trends Biochem. Sci. 22, 437-441.
88. Motohashi, H., Shavit, J. A., Igarashi, K., Yamamoto, M., Engel, J. D. (1997) The world according to Maf. Nucleic Acids Res. 25, 2953-2959.
89. Andrews, N., Erdjument-Bromage, H., Davidson, M., Tempst, P., Orkin, S. H. (1993) Erythroid transcription factor NF-E2 is a hematopoietic-specific basic-leucine zipper protein. Nature (London) 362, 722-728.
90. Shavit, J. A., Motohashi, H., Onodera, K., Akasaka, J-E., Yamamoto, M., Engel, J. D. (1998) Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 12, 2164-2174.
91. Lecine, P., Blank, V., Shivdasani, R. (1998) Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes. J. Biol. Chem. 273, 7572-7578.
92. Moi, P., Kan, Y. W. (1990) Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc. Natl. Acad. Sci. USA 87, 9000-9004.
93. Ney, P. A., Sorrentino, B. P., McDonagh, K. T., Nienhuis, A. W. (1990) Tandem AP-1-binding sites within the human β-globin domainant control region function as an inducible enhancer in erythroid cells. Genes Dev. 4, 993-1006.
94. Talbot, D., Grosveld, F. (1991) The 5′ HS 2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J. 10, 1391-1398.
95. Forsberg, E. C., Downs, K. M., Bresnick, E. H. (2000) Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells. Blood 96, 334-339.
96. Sawado, T., Igarashi, K., Groudine, M. (2001) Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter. Proc. Natl. Acad. Sci. USA 98, 10226-10231.
97. Johnson, K. D., Christensen, H. M., Zhao, B., Bresnick, E. H. (2001) Distinct mechanisms control RNA polymerase II recruitment to a tissuespecific locus control region and a downstream promoter. Mol. Cell 8, 465-471.
98. Shivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D. C., Jackson, W., Hunt, P., Saris, C. J., Orkin, S. H. (1995) Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoieitin/MGDF in megakaryocyte development. Cell 81, 695-701.
99. Shivdasani, R. A., Orkin, S. H. (1995) Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. USA 92, 8690-8694.
100. Kotkow, K. J., Orkin, S. H. (1996) Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus. Proc. Natl. Acad. Sci. USA 93, 3514-3518.
101. Lu, S-J., Rowan, S., Bani, M. R., Ben-David, Y. (1994) Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin gene expression. Proc. Natl. Acad. Sci. USA 91, 8398-8402.
102. Kotkow, K., Orkin, S. H. (1995) Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol. Cell. Biol. 15, 4640-4647.
103. Jimenez, G., Griffiths, S. D., Ford, A. M., Greaves, M. F., Enver, T. (1992) Activation of the beta-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. USA 89, 10618-10622.
104. Gong, Q., McDowell, J. C., Dean, A. (1996) Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the ε-globin gene in vivo by 5′ hypersensitive site 2 of the β-globin locus control region. Mol. Cell. Biol. 16, 6055-6064.
105. Armstrong, J. A., Emerson, B. M. (1996) NF-E2 disrupts chromatin structure at human β-globin locus control region hypersensitive site 2 in vitro. Mol. Cell. Biol. 16, 5634-5644.
106. Cosma, M. P., Tanaka, T., Nasmyth, K. (1999) Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 97, 299-311.
107. Krebs, J. E., Kuo, M. H., Allis, C. D., Peterson, C. L. (1999) Cell cycle-regulated histone acetylation required for expression of the yeast HO gene. Genes Dev. 13, 1412-1421.
108. Bieker, J. J. (2001) Krüppel-like factors: three fingers in many pies. J. Biol. Chem. 276, 34355-34358.
109. Nuez, B., Michalovich, D., Bygrave, A., Ploemacher, R., Grosveld, F. (1995) Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature (London) 375, 316-318.
110. Perkins, A. C., Sharpe, A. H., Orkin, S. H. (1995) Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature (London) 375, 318-322.
111. Wijgerde, M., Gribnau, J., Trimborn, T., Nuez, B., Philipsen, S., Grosveld, F., Fraser, P. (1996) The role of EKLF in human β-globin gene competition. Genes Dev. 10, 2894-2902.
112. Armstrong, J. A., Bieker, J. J., Emerson, B. M. (1998) A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 95, 93-104.
113. Lee, C. H., Murphy, M. R., Lee, J. S., Chung, J. H. (1999) Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells. Proc. Natl. Acad. Sci. USA 96, 12311-12315.
114. Hassan, A. H., Neely, K. E., Workman, J. L. (2001) Histone acetyltransferase complexes stabilize swi/snf binding to promoter nucleosomes. Cell 104, 817-827.
115. Begley, C. G., Green, A. R. (1999) The SCL gene: from case report to critical hematopoietic regulator. Blood 93, 2760-2770.
116. Valge-Archer, V. E., Osada, H., Warren, A. J., Forster, A., Li, J., Baer, R., Rabbitts, T. H. (1994) The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA 91, 8617-8621.
117. Osada, H., Grutz, G., Axelson, H., Forster, A., Rabbitts, T. H. (1995) Association of erythoid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA-1. Proc. Natl. Acad. Sci. USA 92, 9585-9589.
118. Wadman, I. A., Osada, H., Grutz, G. G., Agulnick, A. D., Westphal, H., Forster, A., Rabbitts, T. H. (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid DNA-binding complex which includes the TAL1, E47, GATA-1 and Lbd1/NLI proteins. EMBO J. 16, 3145-3157.
119. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. P., Metcalf, D., Begley, C. G. (1995) Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92, 7075-7079.
120. Robb, L., Elwood, N. J., Elefanty, A. G., Kontgen, F., Li, R., Barnett, L. D., Begley, C. G. (1996) The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15, 4123-4129.
121. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. W., Orkin, S. H. (1996) The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86, 47-57.
122. Shivdasani, R. A., Mayer, E. L., Orkin, S. H. (1995) Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373, 432-434.
123. Visvader, J. E., Fujiwara, Y., Orkin, S. H. (1998) Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12, 473-479.
124. Hoang, T., Paradis, E., Brady, G., Billia, F., Nakahara, K., Iscove, N. N., Kirsch, I. R. (1996) Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood 87, 102-111.
125. Aplan, P. D., Nakahara, K., Orkin, S. H., Kirsch, I. R. (1992) The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11, 4073-4081.
126. Porcher, C., Liao, E. C., Fujiwara, Y., Zon, L. I., Orkin, S. H. (1999) Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development 126, 4603-4615.
127. Lam, L. T., Bresnick, E. H. (1996) A novel DNA-binding protein, HS2NF5, interacts with a functionally important sequence of the human beta-globin locus control region. J. Biol. Chem. 271, 32421-32429.
128. Elnitski, L., Miller, W., Hardison, R. (1997) Conserved E boxes function as part of the enhancer in hypersensitive site 2 of the beta-globin locus control region. Role of basic helix-loop-helix proteins. J. Biol. Chem. 272, 369-378.
129. Huang, S., Brandt, S. J. (2000) mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol. Cell. Biol. 20, 2248-2259.
130. Kwok, R. P., Lunblad, J. R., Chrivia, J. C., Richards, J. P., Bachinger, H. P., Brennan, R. G., Roberts, S. G., Green, M. R., Goodman, R. H. (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (London) 370, 223-226.
131. Yao, T-P., Ku, G., Zhou, N., Scully, R., Livingston, D. M. (1996) The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93, 10626-10631.
132. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S., Heyman, R. A., Rose, D., Glass, C. K., Rosenfeld, M. G. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
133. Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., Rosenfeld, M. G. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature (London) 387, 676-684.
134. Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., Evans, R. M. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
135. Martinez-Balbas, M., Bannister, A., Martin, K., Haus-Seuffert, P., Meisternst, M., Kouzarides, T. (1998) The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17, 2886-2893.
136. Imhof, A., Yang, X. J., Ogryzko, V. V., Nakatani, Y., Wolffe, A. P., Ge, H. (1997) Acetylation of general transcription factors by histone acetyl-transferases. Curr. Biol. 7, 689-692.
137. Wong, J., Patterton, D., Imhof, A., Guschin, D., Shi, Y-B., Wolffe, A. P. (1998) Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. EMBO J. 17, 520-534.
138. Kouzarides, T. (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176-1179.
139. Chen, H., Lin, R. J., Xie, W., Wilpitz, D., Evans, R. M. (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98, 675-686.
140. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., Thanos, D. (1998) Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 2, 457-467.
141. Korzus, E., Torchia, J., Rose, D. W., Xu, L., Kurokawa, R., McInerney, E. M., Mullen, T-M., Glass, C. K., Rosenfeld, M. G. (1998) Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279, 703-707.
142. Miyake, S., Sellers, W. R., Safran, M., Li, X., Zhao, W., Grossman, S. R., Gan, J., DeCaprio, J. A., Adams, P. D., Kaelin Jr., W. G. (2000) Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle. Mol. Cell. Biol. 20, 8889-8902.
143. MacLellan, W. R., Xiao, G., Abdellatif, M., Schneider, M. D. (2000) A novel Rb- and p300-binding protein inhibits transactivation by myoD. Mol. Cell. Biol. 20, 8903-8915.
144. Soutoglou, E., Viollet, B., Vaxillaire, M., Yaniv, M., Pontoglio, M., Talianidis, I. (2001) Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 20, 1984-1992.
145. He, L. Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., Pandolfi, P. P. (1998) Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat. Genet. 18, 126-135.
146. Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., Seiser, C., Grignani, F., Lazar, M. A., Minucci, S., Pelicci, P. (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature (London) 391, 815-818.
147. Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H. J., Evans, R. M. (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (London) 391, 811-814.
148. Merika, M., Williams, A. J., Chen, G., Collins, T., Thanos, D. (1.998) Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription. Mol. Cell 1, 277-287.
149. Takahashi, T., Suwabe, N., Dai, P., Yamamoto, M., Ishii, S., Nakano, T. (2000) (2WO) Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP. Oncogene 19, 134-140.
150. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852.
151. Timmennann, S., Lehrmann, H., Polesskaya, A., Harel-Bellan, A. (2001) Histone acetylation and disease. Cell. Mol. Life Sci. 58, 728-736.
152. Marks, P. A., Richon, V. M., Rifkind, R. A. (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92, 1210-1216.